ADHD Drugs May Ease Perimenopause Brain Fog

Perimenopausal executive dysfunction, commonly known as brain fog, affects a significant portion of women during the transition to menopause. This cognitive decline, characterized by difficulties in planning, focusing, and task switching, shares mechanisms with ADHD. Researchers are exploring whether ADHD medications could offer a treatment, as current options for perimenopausal brain fog are limited.

Preliminary findings from a review of limited data indicate that ADHD medications such as lisdexamfetamine and atomoxetine may help women feel they are functioning better during perimenopause. However, these improvements were primarily based on self-reporting, with objective testing showing less significant changes. Experts suggest this discrepancy may be due to the nature of real-world executive function versus lab-based assessments.

While promising, these findings are based on early, small-scale studies. Clinicians advise a thorough evaluation for other causes of brain fog before considering ADHD medication, and may also explore hormone therapy. Further research is needed to fully understand the efficacy and optimal use of these medications for perimenopausal cognitive symptoms.